Literature DB >> 22161472

Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.

Ayano Matsumoto-Takasaki1, Shinya Hanashima, Ami Aoki, Noriyuki Yuasa, Haruhiko Ogawa, Reiko Sato, Hiroko Kawakami, Mamoru Mizuno, Hiroshi Nakada, Yoshiki Yamaguchi, Yoko Fujita-Yamaguchi.   

Abstract

Tn-antigens are tumour-associated carbohydrate antigens that are involved in metastatic processes and are associated with a poor prognosis. MLS128 monoclonal antibody recognizes the structures of two or three consecutive Tn-antigens (Tn2 or Tn3). Since MLS128 treatment inhibits colon and breast cancer cell growth [Morita, N., Yajima, Y., Asanuma, H., Nakada, H., and Fujita-Yamaguchi, Y. (2009) Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128. Biosci. Trends 3, 32-37.], understanding the interaction between MLS128 and Tn-clusters may allow us to the development of novel cancer therapeutics. Although MLS128 was previously reported to have specificity for Tn3 rather than Tn2, similar levels of Tn2/Tn3 binding were unexpectedly observed at 37°C. Thus, thermodynamic analyses were performed via surface plasmon resonance (SPR) using synthetic Tn2- and Tn3-peptides at 10, 15, 20, 25 and 30°C. SPR results revealed that MLS128's association constants for both antigens were highly temperature dependent. Below 25°C MLS128's association constant for Tn3-peptide was clearly higher than that for Tn2-peptide. At 30°C, however, the association constant for Tn2-peptide was higher than that for Tn3-peptide. This reversal of affinity is due to the sharp increase in K(d) for Tn3. These results were confirmed by NMR, which directly measured MLS128-Tn binding in solution. This study suggested that thermodynamic control plays a critical role in the interaction between MLS128/Tn2 and MLS128/Tn3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161472     DOI: 10.1093/jb/mvr138

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data.

Authors:  Xiangdan Wang; Patrick McKay; Liliana T Yee; George Dutina; Philip E Hass; Ihsan Nijem; David Allison; Kyra J Cowan; Kevin Lin; Valerie Quarmby; Jihong Yang
Journal:  MAbs       Date:  2016-12-21       Impact factor: 5.857

2.  Molecular basis of antibody binding to mucin glycopeptides in lung cancer.

Authors:  Jin Qu; Hongtao Yu; Fenge Li; Chunlei Zhang; Ahmad Trad; Cory Brooks; Bin Zhang; Ting Gong; Zhi Guo; Yunsen Li; Govind Ragupathi; Yanyan Lou; Patrick Hwu; Wei Huang; Dapeng Zhou
Journal:  Int J Oncol       Date:  2015-12-18       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.